IFO50474 NOMO-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
Profile | This cell line is useful for studying the differentiation and maturation of monocytes. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | ||
Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
Case history | acute monocytic leukemia | Metastasis | |
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | round | Character | leukemia, acute monocytic, promonocytic leukemia cells |
Classify | tumor | Established by | Ogura, M. et al. |
Registered by | Ogura,M. | Regulation for Distribution | |
Comment | Year | 1998 | |
Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | Dilution, split ratio 1:4-1:6 |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:1845845 | FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Hamaguchi M,Morishita Y,Takahashi I,Ogura M,Takamatsu J,Saito H Blood. 1991 Jan 1;77(1):94-100 |
Pubmed id:1701357 | Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells. Morishita Y,Kataoka T,Towatari M,Ito T,Inoue H,Ogura M,Morishima Y,Saito H Cancer Res. 1990 Dec 15;50(24):7955-61 |
Pubmed id:1699657 | Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells. Towatari M,Ito Y,Morishita Y,Tanimoto M,Kawashima K,Morishima Y,Andoh T,Saito H Cancer Res. 1990 Nov 15;50(22):7198-202 |
Images |
---|
LOT Information
Cell No. | IFO50474 | Cell Name | |
---|---|---|---|
LOT No. | 01242007 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS lot; GIBCO 484735) | Temperature | 37 C |
Cell Density at Seeding | 1.5 - 2.7 x 10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | approx. 38 hrs | Cell Number in Vial (cells/1ml) | 8.1 x 10^6 |
Viability at cell freezing (%) | 87 | Antibiotics Used | free |
Passage Number | Unknown (12 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
LOT No. | 717 | Lot Specification | distribution |
Medium | RPMI 1640, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | dilution | |
Doubling Time | Cell Number in Vial (cells/1ml) | 2 x 10^6 | |
Viability at cell freezing (%) | 95 | Antibiotics Used | free |
Passage Number | Unknown (7 at IFO) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), AST |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
LOT No. | 11112014 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | 0.4 - 1.6 x 106 | Methods for Passages | Dilution, split ratio 1:4 - 1:6 (approx. 2 - 4 x 10^5 cells/mL) |
Doubling Time | Cell Number in Vial (cells/1ml) | 2.4 x 10^6 | |
Viability at cell freezing (%) | 93.4 | Antibiotics Used | free |
Passage Number | Unknown (5 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:11,13 D13S317:8,10 D7S820:8,10 D16S539:9,11 VWA:17,18 TH01:6,9 AM:X TPOX:8,12 CSF1PO:11,12 |
|
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 93.4 | Additional information |
Cell No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
LOT No. | 02012018 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 1 - 3 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture), split ratio 1:4 - 1:6. |
Doubling Time | approx. 37 hrs. | Cell Number in Vial (cells/1ml) | 3.1 x 10^6 |
Viability at cell freezing (%) | 86 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 86 | Additional information |
Cell No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
LOT No. | 04242020 | Lot Specification | distribution |
Medium | RPMI-1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 1 - 4 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture). |
Doubling Time | approx. 1.5 - 2 days | Cell Number in Vial (cells/1ml) | 6.6 x 10^6 |
Viability at cell freezing (%) | 92.3 | Antibiotics Used | free |
Passage Number | Unknown (6 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 81.4 | Additional information |
Cell No. | IFO50474 | Cell Name | NOMO-1 |
---|---|---|---|
LOT No. | 08072023 | Lot Specification | distribution |
Medium | RPMI1640 medium (GIBCO,Cat No.11875) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396) | Temperature | 37 C |
Cell Density at Seeding | 2.0-2.49x10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 6.07x10^6 |
Viability at cell freezing (%) | 94 | Antibiotics Used | free |
Passage Number | p9* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:11,13 D13S317:8,10 D7S820:8,10 D16S539:9,11 VWA:17,18 TH01:6,9 AM:X TPOX:8,12 CSF1PO:11,12 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | CELLBANKER1((Nihon Zenyaku Industries) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 93 | Additional information |
Images |
---|